GEN-MKT-18-7897-A
Feb 25, 2026 | Blogs, Environmental / Industrial | 0 comments
Read time: 5 Minutes
Waterproof jackets. Stain-resistant shoes. Easy-clean fabrics are marketed as “performance.” Behind those everyday claims sits a class of chemicals now reshaping regulation, brand accountability, and laboratory science: PFAS.
Until recently, much of the conversation around PFAS in textiles was theoretical. That is no longer the case. Laboratories can now measure what is actually present on fabrics at ultra-low levels, revealing which chemistries persist in real consumer garments and raising new questions about how “PFAS-free” claims should be interpreted.
For food and environmental scientists, this marks an important shift. The challenge is no longer limited to tracking contamination in drinking water, wastewater, or environmental exposure pathways. Attention is increasingly turning upstream toward the intentional use of PFAS in consumer products, including textiles, where they are applied to provide water, oil, and stain resistance, as well as thermal stability.
Regulatory momentum reflects this shift. Following a successful effort led by the U.S. Food and Drug Administration to phase out the use of PFAS in food packaging, lawmakers have moved to restrict intentionally added PFAS in other consumer products. New York and California now prohibit the sale of apparel containing “forever chemicals,” with further state-level restrictions expected to follow. In Europe, France and Denmark have current or planned bans on PFAS in textiles.
This is no longer just an environmental monitoring issue. It is becoming a product verification and analytical evidence issue, and laboratories are increasingly central to that conversation.
Why textiles are becoming analytically relevant
PFAS have long been monitored in drinking water, soil, and environmental samples. Regulatory focus is now shifting upstream toward products and materials, including clothing, footwear, upholstery, and waterproofing treatments.
This shift matters because the PFAS mixture on textiles is chemically complex. They can contain mixtures of:
Analytical evidence is now filling an important gap in this conversation.
Our validated LC-MS/MS workflow applied to textiles demonstrated:
This moves the discussion away from assumptions and toward measurable reality.
What laboratories are seeing in real clothing
One of the most striking findings from this technical note is that PFAS were detected not in industrial samples, but in locally purchased consumer garments.
When three shirts and one dhoti labeled as stain- or water-repellent were analyzed:
This is an important learning point for scientists. Although the measured levels were low, the PFAS profile is increasingly dominated by short-chain acids and fluorotelomer-based chemistries, reflecting broader shifts away from long-chain compounds.
Why low-level performance matters
Textiles are not clean analytical matrices. Fibers, dyes, coatings, and finishes introduce background complexity, challenging sensitivity and accuracy.
This is why method performance in matrix matters more than theoretical sensitivity.
During our method development matrix spikes performed directly in cotton fabric showed:
For experienced analysts, this communicates something important: Low-level quantitation in textiles is achievable, but only with workflows designed for contamination control, extraction efficiency, and matrix-specific validation.
Why regulations are making this everyone’s problem
Bans on PFAS in textiles are no longer theoretical. They are already shaping real markets.
State laws in New York and California have forced companies to ban the sale of clothing containing “forever chemicals,” and similar restrictions are scheduled to roll out in more states, and other countries around the globe, in 2026. These developments signal a broader shift toward regulating PFAS at the product level rather than only in environmental samples.
The practical impact of these regulations is not only legal or political. It is analytical.
Regulators define thresholds. Brands make claims. Laboratories are expected to determine what is present.
This creates difficult scientific questions:
These are not marketing problems. They are measurement problems.
What this means for food and environmental laboratories
For many labs, this shift will feel familiar.
The same challenges seen in food, biosolids, packaging, and environmental samples are now appearing in consumer products:
The difference is contextual. Results are no longer used only to assess contamination. They are increasingly used to:
That changes the role of the laboratory from data generator to critical decision enabler.
The takeaway
Those labs that can demonstrate reliable performance in complex matrices, transparent data quality, and defensible low-level quantitation will increasingly shape how PFAS regulation is interpreted in practice.
Supporting this level of performance requires more than sensitivity alone. Laboratories need robust instrumentation, workflows designed to control contamination, and software that supports confident data review and reporting.
SCIEX solutions for PFAS analysis are designed with these realities in mind – from LC-MS/MS systems capable of consistent low-level quantitation, to validated workflows for complex matrices such as textiles, food, and environmental samples, and software tools that help laboratories maintain traceability and data integrity as testing demands evolve.
The full technical note
Quantitation of per- and polyfluoroalkyl substances (PFAS) in textiles
Explore the complete data, workflows, and findings in the technical note
Access now >
References:
As an analytical strategy, middle-down mass spectrometry (MS) workflows characterize biotherapeutic proteins by analyzing large, digested protein fragments or defined subunits, rather than fully intact proteins (top-down) or digested peptides (bottom-up). A middle-down strategy combines the strengths of top-down and bottom-up approaches by delivering high sequence coverage and structural specificity while maintaining relatively simple sample preparation. In practice, middle-down analysis enables accurate mass measurement, rapid sequence confirmation, and localization of key post-translational modifications (PTMs) on protein subunits that are directly relevant to product quality.
In biopharmaceutical development, sequence variants (SV) are considered an inherent risk of producing complex proteins in living systems. Sequence variants are unintended changes to the amino acid sequence of a biotherapeutic and can be caused by errors in transcription or translation in the host cell, or cell culture and process conditions. Detailed analysis of SVs is important in process and product development to ensure the drug’s safety and efficacy. Even low‑level sequence variants can have significant implications for product quality, safety, and efficacy, making their accurate detection and characterization a critical requirement across development, process optimization, and regulatory submission.
CE‑SDS remains a cornerstone assay for characterizing fragmentation, aggregation, and product‑related impurities in therapeutic proteins. UV detection has been the long‑standing standard. However, it frequently struggles with baseline noise, limited sensitivity for minor fragments, and subjective integration.
Posted by
You must be logged in to post a comment.
Share this post with your network